Clinical Trials Directory

Trials / Unknown

UnknownNCT04011956

Prognosis and Integrative Assessment of Aortic Coarctation Patients in China

Prognosis and Integrative Assessment of Aortic Coarctation Patients in CHINA

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Beijing Institute of Heart, Lung and Blood Vessel Diseases · Academic / Other
Sex
All
Age
17 Years
Healthy volunteers
Not accepted

Summary

This is a systemic research of Chinese aortic coarctation patients, aiming to determine risk factors and serial biomarkers of aortic coarctation in prognosis.

Detailed description

The goal is to determine how much the left ventricle remodeling pre-operation and how it changes in the following-up duration after surgery, so does in the blood pressure and heart function. Risk factors associated with complications and prognosis are investigated and analyzed. Identification of novel biomarkers is needed to help predicting the prognosis, such as the left ventricle anti-remodeling, heart function and blood pressure improvement, as well as the exercise tolerance post-operation. The findings of this study will help the investigators developping new tests to monitor affected patients and optimize the operation as well as the follow-up procedure.

Conditions

Timeline

Start date
2019-03-01
Primary completion
2022-12-31
Completion
2023-12-31
First posted
2019-07-09
Last updated
2020-07-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04011956. Inclusion in this directory is not an endorsement.